147 related articles for article (PubMed ID: 18598349)
1. Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study.
Rosner B; Colditz GA; Iglehart JD; Hankinson SE
Breast Cancer Res; 2008; 10(4):R55. PubMed ID: 18598349
[TBL] [Abstract][Full Text] [Related]
2. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
3. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
[TBL] [Abstract][Full Text] [Related]
5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
6. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
7. Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk.
Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
Breast Cancer Res Treat; 2017 Aug; 165(1):215-223. PubMed ID: 28589369
[TBL] [Abstract][Full Text] [Related]
8. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women.
Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA
JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771
[TBL] [Abstract][Full Text] [Related]
9. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
Eliassen AH; Missmer SA; Tworoger SS; Hankinson SE
J Clin Oncol; 2006 Apr; 24(12):1823-30. PubMed ID: 16567770
[TBL] [Abstract][Full Text] [Related]
10. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Manson JE; Colditz GA; Hunter DJ; Spiegelman D; Barbieri RL; Speizer FE
J Natl Cancer Inst; 1998 Sep; 90(17):1292-9. PubMed ID: 9731736
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.
Rice MS; Tworoger SS; Hankinson SE; Tamimi RM; Eliassen AH; Willett WC; Colditz G; Rosner B
Breast Cancer Res Treat; 2017 Nov; 166(1):227-240. PubMed ID: 28702896
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic Activity and Risk of Invasive Breast Cancer Among Postmenopausal Women in the Nurses' Health Study.
Holder EX; Houghton SC; Sanchez SS; Eliassen AH; Qian J; Bertone-Johnson ER; Liu Z; Tworoger SS; Smith MT; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):831-838. PubMed ID: 35131884
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
15. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
16. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
17. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
18. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
20. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JWT; Tice JA; Ziv E; Kerlikowske K; Cummings SR
Breast Cancer Res Treat; 2017 Nov; 166(2):603-612. PubMed ID: 28791495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
